NCT03597139View on ClinicalTrials.gov

Ocular Tolerability of Voclosporin Ophthalmic Solution Versus Restasis® in Subjects With Dry Eye Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 13, 2018

Primary Completion Date

November 9, 2018

Study Completion Date

December 13, 2018

Conditions
Dry Eye
Interventions
DRUG

Voclosporin Ophthalmic Solution

Investigational Drug

DRUG

Restasis®

Comparator

Trial Locations (7)

27262

Aurinia Investigative Center, High Point

38119

Aurinia Investigative Center, Memphis

63090

Aurinia Investigative Center, Washington

64111

Aurinia Investigative Center, Kansas City

91345

Aurinia Investigative Center, Mission Hills

92843

Aurinia Investigative Center, Garden Grove

95670

Aurinia Investigative Center, Rancho Cordova

Sponsors
All Listed Sponsors
lead

Aurinia Pharmaceuticals Inc.

INDUSTRY